ALZHEIMER'S DISEASE AND DEMENTIA
IS A WORLDWIDE CHALLENGE
TODAY, NO CURE IS AVAILABLE
Researchers from ADx have been involved in many Alzheimer biomarker studies. This resulted in 7 posters and 4 oral presentations at the upcoming Alzheimer conference in Washington, July 18-23.
Two posters were selected as a new developing topic:
Development of own proprietary stand-alone biomarkers and in-licensing of newly discovered markers from academic and industrial partners.
Development and co-development of tailor-made new generation companion diagnostics for neurodegenerative disorders.